Celularity Inc. Shareholders' Equity
Celularity Inc. (CELU) had Shareholders' Equity of -$38.06 million as of 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-04-30
- 2025-12-31: Stockholders' Equity Attributable to Parent -$38.06M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$20.09M.
- 2025-06-30: Stockholders' Equity Attributable to Parent -$25.50M.
- 2025-03-31: Stockholders' Equity Attributable to Parent -$5.51M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2025-12-31 | -$38.06M 10-K · filed 2026-04-30 | |
| 2025-09-30 | -$20.09M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$25.50M 10-Q · filed 2025-11-14 | |
| 2025-03-31 | -$5.51M 10-Q · filed 2025-11-14 | |
| 2024-12-31 | $8.84M 10-K · filed 2026-04-30 | |
| 2024-09-30 | $17.28M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $27.81M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $31.25M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $40.96M 10-K · filed 2026-04-30 | |
| 2023-09-30 | $30.25M 10-Q · filed 2024-12-06 | |
| 2023-06-30 | $118.50M 10-Q · filed 2024-12-06 | |
| 2023-03-31 | $155.63M 10-Q · filed 2024-12-06 | |
| 2022-12-31 | $198.90M 10-K · filed 2025-05-08 | |
| 2022-09-30 | $164.24M 10-Q · filed 2024-01-03 | |
| 2022-06-30 | $150.15M 10-Q · filed 2024-01-03 | |
| 2022-03-31 | $89.91M 10-Q · filed 2024-01-03 | |
| 2021-12-31 | $99.42M 10-K · filed 2024-07-30 | |
| 2021-09-30 | $96.22M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$648.21M 10-Q · filed 2022-11-10 | -$47.40M 10-Q · filed 2021-08-19 |
| 2021-03-31 | -$611.93M 10-Q · filed 2022-11-10 | -$39.58M 10-Q · filed 2021-05-24 |
| 2020-12-31 | -$531.40M 10-K · filed 2023-03-31 | $5.00M 10-K · filed 2021-03-04 |
| 2020-09-30 | -$536.41M 10-Q · filed 2021-11-12 | $5.00M 10-Q · filed 2020-11-16 |
| 2020-06-30 | -$490.95M 10-Q · filed 2021-11-12 | $5.00M 10-Q · filed 2020-08-13 |
| 2020-03-31 | -$356.78M 10-Q · filed 2021-11-12 | $5.00M 10-Q · filed 2020-05-15 |
| 2019-12-31 | -$327.42M 10-K · filed 2022-03-31 | $5.00M 10-K · filed 2020-03-24 |
| 2019-09-30 | $5.00M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $5.00M 10-Q · filed 2020-11-16 | |
| 2019-03-31 | $23.78K 10-Q · filed 2020-11-16 | |
| 2018-12-31 | $23.90K 10-K/A · filed 2021-05-24 | |
| 2018-09-30 | $24.45K 10-Q · filed 2019-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |